NCT05730621CompletedPhase 4
A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease
A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease; A Prospective, Randomized, Parallel, Open-Label, Single-center, Phase IV Clinical Trial
Source: ClinicalTrials.gov · Last updated 22 Jan 2025
Brief summary (registry, in English)
This study is to compare the effects of sarpogrelate sustained release /aspirin combination therapy versus aspirin on blood viscosity in the patients with peripheral arterial disease and coronary artery disease
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 68 (actual)
- First submitted
- 26 Jan 2023
- Start date
- 11 Jan 2023
- Primary completion date
- 28 Feb 2024
- Lead sponsor
- Yuhan Corporation
- Diseases
- Coronary artery disease
- NCT number
- NCT05730621
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 68
- From 11 Jan 2023 to the primary completion date, 28 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have taken aspirin within two weeks before randomization
- Patients who need antiplatelet or anticoagulant medication except Aspirin
- Those participating in other clinical trials for investigational products
Other illness
- Patients who is scheduled surgery due to coronary artery disease or cerebral infarction disease.
- Patients with a history of cerebrovascular and cardiovascular complications (brain infarction, transient cerebral ischemic seizures, myocardial infarction, unstable angina, coronary artery bypass graft, percutaneous coronary artery intervention) within the last six months
- Patients with bleeding
Lab values
- Confirmed below results at screening
- Hemoglobin \<13g/dL
- Platelet \<60,000/µL
- Severe kidney disease patient with eGFR(estimated Glomerular Filtration Rate) \<30 mL/min/1.73 m2 (CKD-EPI)
Other
- Pregnant or lactating women
- Patients deemed to be ineligible to participate in the trial by investigator
Who the study is looking for
- Both man and woman who is over 19 years old
- Identified as 10-75% of Stenosis in Coronary Angiography or Coronary CTA(Coronary computed tomography angiography)
- Patients who diagnosed with peripheral artery disease or has symptoms
- Written informed consent
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Catholic University of Korea Uijeongbu St. Mary's Hospital Coordinator of this site? Confirm its status | Uijeongbu-si | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.